ID   MAST
AC   CVCL_M374
DR   cancercelllines; CVCL_M374
DR   IARC_TP53; 13987
DR   Wikidata; Q54904039
RX   PubMed=8601577;
RX   PubMed=10841287;
CC   Doubling time: ~68 hours (PubMed=8601577).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Ser (c.730G>A); ClinVar=VCV000376600; Zygosity=Unspecified (PubMed=10841287).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
RX   PubMed=8601577; DOI=10.1007/BF01209652;
RA   Zoli W., Roncuzzi L., Flamigni A., Gruppioni R., Sensi A., Zini N.,
RA   Amadori D., Gasperi-Campani A.;
RT   "A new cell line from human infiltrating ductal carcinoma of the
RT   breast: establishment and characterization.";
RL   J. Cancer Res. Clin. Oncol. 122:237-242(1996).
//
RX   PubMed=10841287;
RA   Calistri D., Barzanti F., Dal Susino M., Fedriga R., Saragoni L.,
RA   Bernardi L., Ricotti L., Zoli W.;
RT   "Correlation between p53 gene mutations and p53 protein accumulation
RT   evaluated by different methodologies.";
RL   J. Biol. Regul. Homeost. Agents 14:120-127(2000).
//